Makers Laboratories Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 ,inter alia, to consider and approve Standalone and Consolidated ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Makers Laboratories Ltd has informed BSE that its Board of Directors will meet on Tuesday, 10th February 2026 to consider and approve the Standalone and Consolidated Unaudited Financial Results for the third quarter and nine months ended 31st December 2025 (Q3FY26). This is a routine regulatory disclosure under SEBI Listing Regulations. The trading window for insiders has been closed since 1st January 2026 and will remain closed until 48 hours after the results are declared, i.e. till 12th February 2026. The filing was signed by Company Secretary Piyush Ajmera on 21st January 2026. No financial details or estimates have been shared at this stage.
This is a procedural notice with no immediate impact on the stock. Investors should watch for the actual Q3FY26 results on 10th February 2026, which will provide clarity on the company's quarterly performance and any key business updates.